About us

Lumobiotics develops light-controllable peptide drugs as safe cytolytic agents for treatment of solid cancers and localized infectious diseases. We are dedicated to fostering the development of chemotherapeutic s based on the technology platform, utilizing molecular photoswitches. As a university Spin-off we perform rigorous science translating into societal benefit.

Management team

Dr Oleg Babii
Co-founder
CEO
Kateryna Tolmachova
Kateryna Tolmachova
Co-founder
Tim Schober
Co-founder
COO

Scientific advisors

Prof. Igor Komarov
Co-founder
Scientific advisor
Dr Sergii Afonin
Co-founder
Scientific advisor

External advisors

Immuno-oncology discovery program is being implemented under scientific advise of Prof. Viktor Umansky (German Cancer Research Center (DKFZ), Heidelberg, Germany

Partners